Discovery of undescribed steroids with anti-inflammatory and anti-hepatic fibrosis activities from the Formosan soft coral Sclerophytum leptoclados Authors: Thanh Hao Huynh, Hsin-Lan Huang, Po-Jen Chen, Yu-Chia Chang, Tsong-Long Hwang Published: 2026 ABSTRACT Four new steroids, 8βH-3β,7α,11-trihydroxy-24-methylene-9,11-secocholest-5-en-9-one (1), 3β,5α,12α-trihydroxy-cholest-6(7),9(11),24(28)-trien (2), 3β,7α,12α-trihydroxy-cholest-5(6),9(11),24(28)-trien (3), and (24S)-3β,7α,12α-trihydroxy-cholest-5(6),9(11)-dien (4), together with two putatively unreported steroids, 8αH-3β-hydroxy-11-acetoxy-24-methylene-9,11-secocholest-5-en-9-one (5) and 8αH-(24R)-11-acetoxy-3β-hydroxy-24-methyl-9,11-secocholest-5,22E-dien-9-one (6), and six known analogues, 3β-hydroxy-11-acetoxy-24-methylene-9,11-secocholest-5-en-9-one (7), (24R)-11-acetoxy-3β-hydroxy-24-methyl-9,11-secocholest-5,22E-dien-9-one (8), (24S)-3β-hydroxy-11-acetoxy-24-methyl-9,11-secocholest-5-en-9-one (9), 3β,11-dihydroxy-9,11-secogorgost-5-en-9-one (10), 3β,11-dihydroxy-24-methylene-9,11-secocholestan-9-one (11), and 8βH-3β,11-dihydroxy-24-methylene-9,11-secocholest-5-en-9-one (12), were isolated from the ethyl acetate extract of the soft coral Sclerophytum leptoclados, collected from the waters off Taiwan. The structures of compounds 1–4 were elucidated by comprehensive spectroscopic analyses, including mass spectrometry and one- and two-dimensional NMR experiments, whereas the structures of compounds 5 and 6 were tentatively assigned based primarily on detailed NMR spectroscopic analyses. The anti-inflammatory activities of these steroids were evaluated by examining their inhibitory effects on superoxide anion generation and elastase release in human neutrophils. Compounds 2, 11, and 12 exhibited potent inhibitory activities, with IC50 values ranging from 2.23 to 5.90 µM. In addition, isolated compounds were evaluated for their anti-hepatic fibrosis potential by examining their inhibitory effects on human hepatic stellate (LX-2) cells. Compounds 7, 10, 11, and 12 significantly reduced LX-2 cell viability, with IC50 values ranging from 2.61 to 3.47 µM. Introduction Octocorals belonging to the genus Sclerophytum, previously known as Sinularia,1 are widely distributed throughout the world's oceans and have been recognized as a major source of marine natural products.2–6 The members of this genus are well known for producing structurally diverse and complex secondary metabolites, including sesquiterpenes, nor-sesquiterpenes, diterpenes, nor-diterpenes, steroids, and steroidal glycosides. These compounds display a broad spectrum of biological activities, such as cytotoxic, anti-inflammatory, and antimicrobial effects.3 Terpenoids and steroids represent the predominant classes of compounds isolated from Sclerophytum species. Sclerophytum-derived terpenoids display remarkable structural diversity and a wide range of biological activities, including cytotoxic, anti-inflammatory, antimicrobial, and antimalarial effects.4 Steroids isolated from these corals are mainly ergostane-type steroids and 9,11-secosteroids, often characterized by a high degree of oxidation.2 Numerous studies have demonstrated that steroids from soft corals exhibit diverse biological activities, such as anticancer, anti-inflammatory, antiviral, and antibacterial properties.3,7 Owing to their diverse and potent biological activities, natural products derived from Sclerophytum have garnered increasing interest as valuable lead structures for the development of novel pharmaceutical agents and functional biomolecules. In the context of our continuous interest for the isolation of bioactive compounds from marine organisms, the chemical compositions and bioactivity of the soft coral Sclerophytum leptoclados, collected from Taiwan waters, were investigated. We report herein the isolation, structural determination, anti-inflammatory and anti-hepatic fibrosis activities evaluation of four new steroids, 8βH-3β,7α,11-trihydroxy-24-methylene-9,11-secocholest-5-en-9-one (1), 3β,5α,12α-trihydroxy-cholest-6(7),9(11),24(28)-trien (2), 3β,7α,12α-trihydroxy-cholest-5(6),9(11),24(28)-trien (3), and (24S)-3β,7α,12α-trihydroxy-cholest-5(6),9(11)-dien (4), two putatively unreported steroids, 8αH-3β-hydroxy-11-acetoxy-24-methylene-9,11-secocholest-5-en-9-one (5) and 8αH-(24R)-11-acetoxy-3β-hydroxy-24-methyl-9,11-secocholest-5,22E-dien-9-one (6), and their six known analogues, 3β-hydroxy-11-acetoxy-24-methylene-9,11-secocholest-5-en-9-one (7), (24R)-11-acetoxy-3β-hydroxy-24-methyl-9,11-secocholest-5,22E-dien-9-one (8), (24S)-3β-hydroxy-11-acetoxy-24-methyl-9,11-secocholest-5-en-9-one (9), 3β,11-dihydroxy-9,11-secogorgost-5-en-9-one (10), 3β,11-dihydroxy-24-methylene-9,11-secocholestan-9-one (11), and 8βH-3β,11-dihydroxy-24-methylene-9,11-secocholest-5-en-9-one (12) (Fig. 1). The structures of steroids 1–12. Results and discussion Compound 1 was obtained as a colorless oil, and its molecular formula was determined to be C28H46O4, corresponding to six degrees of unsaturation. This was established from an ESIMS peak at m/z 469 [M + Na]+ and further confirmed by a HRESIMS peak at m/z 469.3289 (calcd. for C28H46O4 + Na, 469.3293). The IR spectrum of 1 showed characteristic absorption bands for hydroxy and ketone functionalities at vmax 3333 and 1713 cm−1, respectively. Analysis of the 13C and DEPT NMR spectra of 1 revealed 28 carbon resonances, including one ketone carbonyl carbon, four olefinic carbons, and three oxygenated carbons, with the remaining signals attributable to five methyl, eight sp3 methylene, five sp3 methine, and two sp3 quaternary carbons (Table 1). The 1H NMR data of 1, in combination with the HSQC spectrum, indicated the presence of an exocyclic double bond (Δ24(28)) and a trisubstituted double bond (Δ5). In addition, signals corresponding to one oxygenated methylene (CH2-11) and two oxygenated methines (CH-3, CH-7) were observed. The spectra also displayed two singlet methyl groups (CH3-18 and CH3-19) and three doublet methyl groups (CH3-21, CH3-26, and CH3-27) (Table 1). These spectroscopic features indicated that 1 possesses a 9,11-secosteroid skeleton, similar to those previously reported.6,8 Table 1 1H and 13C NMR data for steroids 1–4Position1a2a3a4b δ H (J in Hz) δ C, multc δ H (J in Hz) δ C, multc δ H (J in Hz) δ C, multc δ H (J in Hz) δ C, multc11.55 m; 1.98 m30.6, CH21.37 m; 2.11 m28.2, CH21.22 m; 2.05 m34.6, CH21.38 m; 2.08 m34.7, CH221.57 m; 1.87 m30.8, CH21.62 m; 2.09 m30.5, CH21.64 m; 2.00 m31.5, CH21.65 m; 1.97 m31.4, CH233.59 m71.0, CH4.09 m66.7, CH3.57 m71.4, CH3.57 m71.4, CH42.31 m; 2.46 m40.3, CH21.65 m; 1.89 m40.2, CH22.32 m; 2.37 m41.7, CH22.25 m; 2.35 m41.7, CH25146.5, C74.4, C143.7, C143.6, C65.76 dd (6.4, 1.6)124.2, CH5.69 m130.6, CH5.78 dd (5.6, 1.6)124.2, CH5.78 dd (7.2, 3.6)124.2, CH74.45 m71.6, CH5.58 m133.0, CH3.96 m65.2, CH3.96 m65.2, CH83.10 dd (9.6, 4.0)50.8, CH2.58 m39.6, CH2.17 m41.9, CH2.19 m41.9, CH9215.3, C145.4, C147.3, C147.3, C1049.0, C41.9, C39.0, C39.0, C113.71 m; 3.96 m59.5, CH25.62 m122.9, CH5.88 d (6.4)122.9, CH5.89 d (6.6)122.9, CH121.24 m; 1.72 m40.3, CH23.99 d (4.0)71.8, CH4.02 d (6.4)71.9, CH4.02 d (6.6)71.9, CH1345.5, C45.6, C45.1, C45.0, C142.78 m39.6, CH1.54 m43.9, CH2.16 m38.6, CH2.13 m38.5, CH151.41 m; 1.84 m24.7, CH21.36 m; 1.96 m27.8, CH21.22 m; 1.86 m24.6, CH21.88 m24.6, CH2161.41 m; 1.84 m24.8, CH21.34 m; 1.88 m24.6, CH21.38 m; 1.96 m28.4, CH21.33 m; 2.01 m28.4, CH2171.72 m49.1, CH1.86 m47.0, CH1.93 m46.9, CH1.85 m49.9, CH180.67 s17.5, CH30.65 s11.0, CH30.63 s11.2, CH30.63 s11.2, CH3191.38 s21.2, CH31.15 s20.8, CH31.22 s26.7, CH31.22 s26.6, CH3201.41 m33.8, CH1.43 m35.5, CH1.42 m35.5, CH1.37 m35.9, CH211.00 d (6.8)19.3, CH31.01 br d (6.8)17.6, CH31.02 d (6.8)17.7, CH30.99 d (6.6)17.9, CH3221.13 m; 1.54 m34.0, CH21.24 m; 1.59 m34.6, CH21.64 m; 2.09 m3.73, CH21.02 m; 1.45 m33.6, CH231.91 m; 2.12 m31.9, CH21.95 m; 2.11 m31.1, CH21.59 m; 2.13 m31.0, CH20.97 m; 1.40 m31.0, CH224156.6, C156.7, C156.8, C1.21 m39.1, CH252.22 m33.9, CH2.23 m33.8, CH2.25 m33.8, CH1.58 m31.5, CH261.02 d (6.8)21.8, CH31.03 br d (6.8)21.9, CH31.04 d (6.8)21.9, CH30.78 d (6.6)17.6, CH3271.02 d (6.8)22.0, CH31.04 br d (6.8)22.0, CH31.03 d (6.8)22.0, CH30.86 d (6.6)20.5, CH3284.65 br s; 4.72 br s106.2, CH24.67 s; 4.72 s106.0, CH24.67 br s; 4.72 br s106.0, CH20.79 d (6.6)15.5, CH3aSpectra recorded at 400 MHz for 1H and at 100 MHz for 13C in CDCl3 at 25 °C.bSpectra recorded at 600 MHz for 1H and at 150 MHz for 13C in CDCl3 at 25 °C.cMultiplicity deduced by DEPT and HSQC spectra. 1H and 13C NMR data for steroids 1–4 Spectra recorded at 400 MHz for 1H and at 100 MHz for 13C in CDCl3 at 25 °C. Spectra recorded at 600 MHz for 1H and at 150 MHz for 13C in CDCl3 at 25 °C. Multiplicity deduced by DEPT and HSQC spectra. The planar structure of 1 was elucidated through detailed analysis of 2D NMR spectroscopic data. Interpretation of the 3J1H–1H correlations observed in the COSY spectrum enabled the identification of four continuous spin systems, including H2-1/H2-2/H-3/H2-4, H-6/H-7/H-8/H-14/H2-15/H2-16/H-17/H-20/H2-22/H2-23, H2-11/H2-12, H-17/H3-21, H-25/H3-26, and H-25/H3-27 (Fig. 2). Key 2J and 3J heteronuclear correlations observed in the HMBC spectrum, such as those from H2-4, H-7, H3-19/C-5, H-8, H3-19/C-9, H2-2, H2-4, H-6, H-8, H3-19/C-10, H-8, H2-12, H-17, H3-18/C-13, and H2-23, H-25, H3-26, H3-27, H2-28/C-24 further supported the proposed carbon framework (Fig. 2). These key COSY and HMBC correlations collectively confirmed the presence of a 9,11-secosteroid skeleton for 1. The locations of the hydroxy groups at C-3, C-7, and C-11 were determined from the HMBC correlations of H2-2/H2-4 to C-3 (δC 71.0), H-6/H-8 to C-7 (δC 71.6), and H2-12 to C-11 (δC 59.5), respectively (Fig. 2). The relative configuration of 1 was determined by analysis of selective NOE correlations observed in the NOESY spectrum. As shown in Fig. 3, NOESY correlations H3-18/H-14; H3-19/H-4β (δH 2.31), H-7, H-8; H-4α (δH 2.46)/H-3, indicated that OH-3, H-8, H3-18 and H3-19 were β-oriented, whereas OH-7 was α-oriented. In addition, correlations of H-17/H-14, H3-21 suggested that H-14 and H-17 were α-oriented, similar to H3-21. Accordingly, the relative configuration of 1 was assigned as 3S*,7R*,8R*,10S*,13R*,14S*,17R*,20R*. On the basis of these spectroscopic analyses, compound 1 was identified as a new steroid and was named 8βH-3β,7α,11-trihydroxy-24-methylene-9,11-secocholest-5-en-9-one. It should be noted that the stereochemical assignments of the isolated steroids were based on relative configurations established from NOESY analyses and comparison with spectroscopic data of structurally related compounds reported in the literature. Although this approach is widely accepted for steroid structure elucidation, the absolute configurations of the isolated compounds were not experimentally determined in the present study. Therefore, the assigned stereochemistries should be regarded as relative, and further investigations using X-ray crystallography, ECD analysis, or other chiroptical methods will be required to establish their absolute configurations. Key COSY (bold line) and HMBC (arrow) correlations of steroids 1–6. Selective NOESY (double-headed arrow) correlations of steroids 1–8. Compound 2 was obtained as a colorless oil. Its molecular formula was established as C28H44O3 (seven degrees of unsaturation) based on the observation of a sodium adducted ion peak at m/z 451 [M + Na]+ in the ESIMS and m/z 451.3166 (calcd. for C28H44O3 + Na, 451.3188) in the HRESIMS spectrum. The IR spectrum exhibited an absorption band at vmax 3387 cm−1, indicative of the presence of a hydroxy group. Analysis of the 1H, 13C, DEPT, and HSQC NMR spectra of 2 revealed the presence of one exocyclic, one disubstituted, and one trisubstituted carbon–carbon doubled bonds, two oxygenated secondary carbons, one oxygenated tertiary carbon, two singlet methyl groups and three doublet methyl groups (Table 1). The planar structure of 2 was unambiguously elucidated through interpretation of COSY and HMBC correlations (Fig. 2), the positions of OH-3, OH-5, and OH-12 were assigned based on HMBC correlations from H2-2, H2-4/C-3; H2-4, H-6, H-7, H3-19/C-5; and H3-18/C-12, respectively. In the NOESY spectrum, H3-18 showed correlations with H-8 and H-12; H3-19 correlated with H-4β (δH 1.65) and H-8; H-8 correlated with H-12; and H-3 correlated with H-4α (δH 1.89). These correlations indicated that OH-3 and H-8 are β-oriented, consistent with the orientations of H3-18 and H3-19, whereas OH-12 is α-oriented (Fig. 3). Furthermore, correlations of H3-21 with H-17 and of H-17 with H-14 suggested that H-14 and H-17 are located on the same α-face as H3-21 (Fig. 3). One proton of CH2-4 (H-4β) showed a NOESY correlation with H3-19, indicating close spatial proximity between CH2-4 and CH3-19; based on the molecular model, this observation supports an α-orientation for OH-5 (Fig. 3). Accordingly, the relative configuration of 2 was assigned as 3S*,5S*,8S*,10R*,12S*,13R*,14S*,17R*,20R*. Compound 2 was thus identified as a new steroid and named 3β,5α,12α-trihydroxy-cholest-6(7),9(11),24(28)-trien. Compound 3 was isolated as a colorless oil. Its molecular formulas were established as C28H44O3 (seven degrees of unsaturation) based on the HRESIMS sodium adducted ion peak at m/z 451.3188 [M + Na]+ (calcd. for C28H44O3 + Na, 451.3188). The IR spectrum exhibited an absorption band at vmax 3332 cm−1, indicating the presence of hydroxy functionality. Detailed analysis of the 1H, 13C, DEPT, and HSQC NMR spectra revealed that 3 possesses a structure closely related to that of 2, except that the oxygenated tertiary carbon at C-5 and the disubstituted double bond (Δ6) in 2 are replaced in 3 by a trisubstituted olefin Δ5 (δC 143.7, C-5; δH 5.78, 1H, dd, J = 5.6, 1.6/δC 124.2, CH-6) and an oxygenated secondary carbon (δH 3.96, 1H, m/δC 65.2, CH-7). The complete structure of 3 was unambiguously established by comprehensive analysis of the COSY, HMBC, and NOESY spectra (Fig. 2 and 3). The hydroxy groups at C-3, C-7, and C-12 were located by the HMBC correlations of H2-4/C-3, H-6/C-7, and H3-18/C-12, respectively. The relative configurations of the stereogenic centers at C-3, C-7, C-8, C-10, C-12, C-13, C-14, C-17, and C-20 were assigned based on the NOESY correlations of H-3/H-4α, H-4β/H3-19, H-7/H-8, H-7/H-12, H-7/H3-18, and H-14/H-17/H3-21. Accordingly, the relative stereochemistry of 3 was assigned as 3S*,7R*,8S*,10S*,12S*,13R*,14S*,17R*,20R*. Compound 3 was thus identified as a new steroid and named 3β,7α,12α-trihydroxy-cholest-5(6),9(11),24(28)-trien. Compound 4 was obtained as a colorless oil. Its molecular formula was confirmed as C28H46O3 (six degrees of unsaturation) based on the HRESIMS sodium adducted ion peak at m/z 453.3332 [M + Na]+ (calcd. for C28H46O3 + Na, 453.3344). Interpretation of the 1H, 13C, DEPT, and HSQC NMR data indicated that 4 possesses a structure closely related to that of 3, except that the exocyclic olefin moiety (Δ24(28)) in 3 is replaced in 4 by an sp3 methine (δH 1.21, 1H, m/δC 39.1, CH-24) and a doublet methyl group (δH 0.79, 3H, d, J = 6.6/δC 15.5, CH3-28). The complete structure of 4 was unambiguously elucidated through detailed analysis of COSY, HMBC, and NOESY correlations (Fig. 2 and 3). The α-orientation of Me-28 in 4 was confirmed by comparison of the 13C NMR chemical shifts of C-24 (δC 39.1), C-25 (δC 31.5), and C-26 (δC 17.6) with those reported for 28α-methyl analogues (δC 39.13–39.17, C-24; δC 31.54–31.58, C-25; δC 17.64–17.68, C-26) in the literature.9 Accordingly, the relative configuration of 4 was assigned as 3S*,7R*,8S*,10S*,12S*,13R*,14S*,17R*,20R*. Compound 4 was thus identified as a new steroid and named (24S)-3β,7α,12α-trihydroxy-cholest-5(6),9(11)-dien. Compound 5 was isolated as a colorless oil in a diastereomeric mixture with compound 7 in an approximate molar ratio of 1.0 : 1.6, as determined by integration of 1H NMR signals (Fig. S44–S46). The IR spectrum exhibited absorption bands at vmax 3394 and 1712 cm−1, consistent with the presence of hydroxy and ketone functionalities, respectively. Although 5 and 7 were obtained as an inseparable mixture, their NMR resonances were well resolved, allowing unambiguous assignment of individual 1H and 13C chemical shifts for both components (Table 2). Detailed analysis of the NMR data led to the identification of compound 7 as 8βH-3β-hydroxy-11-acetoxy-24-methylene-9,11-secocholest-5-en-9-one, a known 9,11-secosteroid previously reported in the literature.6 Interpretation of the NMR data for 5 revealed that it shares the same planar structure as 7 (Fig. 2). However, significant differences were observed for the resonances of CH-8 in 5 (δH 2.79, 1H, m/δC 43.4) compared with those of 7 (δH 2.98, 1H, m/δC 42.4, CH-8), indicating a difference in configuration at the C-8 stereogenic center between the two compounds. In the NOESY spectrum of 5, correlations of H3-19 with H-4β (δH 2.23); H-4α (δH 2.41) with H-3; H3-21 with H-17; H-17 with H-14; and H-14 with H-8 were observed. These correlations indicated that OH-3 is β-oriented, consistent with Me-19, whereas H-8, H-14, and H-17 are α-oriented, consistent with Me-21 (Fig. 3). The α-orientation of H-8 is further supported by the pronounced upfield shift of its resonance, from δH 2.98 in 7 to δH 2.79 in 5, in agreement with previously reported observations.6 In addition, 5 showed a weak COSY cross-peak between H-8 and H-15, together with a small apparent splitting (J = 1.6 Hz) for the multiplet signal of H-8. This feature may arise from a long-range 4JHHW-coupling through the H-8/C-8/C-14/C-15/H-15 pathway and was considered supporting evidence for the distinct local geometry of the 8α-H epimer. Accordingly, the relative configuration of 5 was assigned as 3S*,8R*,10S*,13R*,14S*,17R*,20R*. The molecular formula of 5 was proposed as C30H48O4 (seven degrees of unsaturation) based on the ESIMS sodium adduct ion peak at m/z 495 [M + Na]+. However, HRESIMS analysis did not provide satisfactory confirmation of the molecular formula, as the observed protonated molecular ion peak at m/z 473.3703 [M + H]+ showed a mass error of 15 ppm relative to the calculated value for C30H49O4+ (m/z 473.3631). Nevertheless, the molecular formula was supported by comprehensive NMR spectroscopic analysis and its close structural relationship to co-occurring secosteroids. Accordingly, compound 5 was characterized as a putatively undescribed steroid and named 8αH-3β-hydroxy-11-acetoxy-24-methylene-9,11-secocholest-5-en-9-one. Extensive chromatographic efforts were made to separate compounds 5 and 7, however, these attempts were unsuccessful, likely due to the well-recognized difficulty of resolving closely related enantiomers or diastereomers composed solely of C, H, and O atoms by conventional chromatographic methods.10 Table 2 1H and 13C NMR data for steroids 5–8Position5a6a7a8a δ H (J in Hz) δ C, multb δ H (J in Hz) δ C, multb δ H (J in Hz) δ C, multb δ H (J in Hz) δ C, multb11.29 m; 1.79 m31.2, CH21.50 m; 1.86 m31.2, CH21.35 m; 1.90 m31.1, CH21.50 m; 1.84 m31.2, CH221.38 m; 1.83 m30.8, CH21.50 m; 1.94 m30.8, CH21.52 m; 1.97 m30.7, CH21.50 m; 1.91 m30.8, CH233.52 m71.5, CH3.50 m71.5, CH3.49 m71.4, CH3.50 m71.5, CH42.23 m; 2.41 m40.7, CH22.28 m; 2.43 m39.5, CH22.22 m; 2.41 m40.6, CH22.25 m; 2.40 m40.7, CH25140.3, C140.2, C140.3, C140.3, C65.48 d (5.6)121.3, CH5.48 d (5.6)121.3, CH5.47 d (5.6)121.2, CH5.48 d (5.6)121.3, CH71.95 m; 2.05 m32.1, CH22.09 m; 2.42 m32.1, CH22.10 m; 2.41 m32.0, CH22.04 m; 2.39 m32.3, CH282.79 m43.4, CH2.45 m42.5, CH2.98 m42.4, CH2.99 m42.8, CH9215.1, C215.1, C215.2, C215.1, C1048.1, C47.9, C47.9, C48.0, C114.09 m61.4, CH24.17 m; 4.20 m61.4, CH24.16 t (7.2)61.4, CH24.17 m; 4.20 m61.5, CH2121.40 m; 1.72 m36.3, CH21.46 m; 1.78 m36.5, CH21.71 m; 1.78 m36.2, CH21.48 m; 1.74 m36.3, CH21345.5, C45.4, C45.3, C45.4, C142.49 m41.4, CH2.40 m41.4, CH2.49 m41.3, CH2.46 m41.7, CH151.30 m; 1.76 m23.8, CH21.13 m; 1.66 m24.6, CH21.30 m; 1.58 m23.7, CH21.32 m; 1.57 m24.0, CH2161.43 m; 1.67 m25.5, CH21.35 m; 1.76 m25.6, CH21.32 m; 1.83 m25.5, CH21.33 m; 1.67 m24.9, CH2171.38 m49.4, CH1.66 m49.6, CH1.64 m49.5, CH1.67 m50.0, CH180.70 s17.2, CH30.70 s17.1, CH30.70 s17.1, CH30.71 s17.5, CH3191.35 s22.8, CH31.35 s23.0, CH31.35 s23.0, CH31.36 s23.0, CH3202.24 m33.8, CH2.18 m38.1, CH2.22 m33.7, CH2.19 m38.1, CH210.99 d (6.8)19.3, CH30.97 d (6.8)22.8, CH30.97 d (6.8)19.2, CH31.04 d (6.8)22.0, CH3221.07 m; 1.46 m34.1, CH25.22 m134.3, CH1.15 m; 1.54 m34.0, CH25.26 m134.3, CH231.74 m31.8, CH25.22 m133.0, CH1.86 m; 2.19 m31.7, CH25.20 m133.0, CH24156.7, C1.84 m43.1, CH156.5, C1.84 m43.1, CH251.37 m34.4, CH1.45 m34.4, CH1.41 m34.2, CH1.45 m33.1, CH261.02 d (6.8)22.0, CH30.85 d (6.8)19.3, CH31.00 d (6.8)21.9, CH30.81 d (6.8)19.7, CH3271.03 d (6.8)21.8, CH30.86 d (6.8)22.6, CH31.02 d (6.8)21.8, CH30.83 d (6.8)22.0, CH3284.64 br s; 4.70 br s106.2, CH20.90 d (6.8)17.1, CH34.64 br s; 4.70 br s106.1, CH20.90 d (6.8)17.6, CH3OAc2.00 s21.1, CH32.00 s21.1, CH31.99 s21.1, CH32.02 s21.1, CH3171.1, C171.1, C171.1, C171.1, CaSpectra recorded at 400 MHz for 1H and at 100 MHz for 13C in CDCl3 at 25 °C.bMultiplicity deduced by DEPT and HSQC spectra. 1H and 13C NMR data for steroids 5–8 Spectra recorded at 400 MHz for 1H and at 100 MHz for 13C in CDCl3 at 25 °C. Multiplicity deduced by DEPT and HSQC spectra. Compound 6 was obtained as a colorless oil in a diastereomeric mixture with compound 8 in an approximate molar ratio of 1.2 : 1.0, as determined by integration of 1H NMR signals (Fig. S58 and S59). The IR spectrum showed characteristic absorption bands at vmax 3394 and 1712 cm−1, indicating the presence of hydroxy and ketone functionalities, respectively. Despite being isolated as an inseparable mixture, the NMR resonances of 6 and 8 were well resolved, allowing unambiguous assignment of their individual 1H and 13C NMR data (Table 2). Compound 8 was identified as leptosterol B by comparison of its 1H and 13C NMR data with those reported in the literature.11 In contrast, the complete structure of 6, including the relative configurations of all stereogenic centers, was established through comprehensive analysis of 1D and 2D NMR spectra, including COSY, HMBC, and NOESY experiments (Fig. 2 and 3). Comparison of the spectroscopic data revealed that 6 and 8 differ only in the configuration at C-8, 6 possesses an α-oriented proton at C-8, whereas 8 bears a β-oriented proton at this position. The α-orientation of H-8 was supported by an upfield shift of its resonance, from δH 2.99 in 8 to δH 2.45 in 6, consistent with previously reported observations.6 In addition, the α-orientation of Me-28 in 6 was assigned by comparison of the 13C NMR chemical shift of CH3-28 with those reported for 28α-methyl analogues in the literature.9 Accordingly, the relative configuration of 6 was assigned as 3S*,8R*,10S*,13R*,14S*,17R*,20R*,24R*. The molecular formula of 6 was tentatively assigned as C30H48O4 (seven degrees of unsaturation) from the ESIMS peak at m/z 473 [M + Na]+. Although HRESIMS analysis yielded a protonated molecular ion peak at m/z 473.3719 [M + H]+, the observed mass error (18.6 ppm) was higher than expected for reliable molecular formula confirmation. Nevertheless, the proposed formula was consistent with the NMR spectroscopic data and the structural features of related secosteroids. Therefore, compound 6 was regarded as a putatively undescribed steroid and named 8αH-(24R)-11-acetoxy-3β-hydroxy-24-methyl-9,11-secocholest-5,22E-dien-9-one. The first natural 8α-H 9,11-secosteroid was reported in 1983 from Sinularia sp.,6 where 8αH-3β,11-dihydroxy-24-methylene-9,11-secocholest-5-en-9-one was identified as the C-8 epimer of the corresponding 8βH analogue. This discovery demonstrated that C-8 epimerism can be distinguished by characteristic NMR features, with the 8αH epimer exhibiting an upfield-shifted H-8 resonance. Base-catalysed conversion of the 8βH analogue into the 8αH epimer further established the configurational lability of C-8, while supporting the natural origin of the isolated 8αH metabolite.6 Since then, natural 8αH-9,11-secosteroids have remained exceptionally rare and, based on current literature, appear to be confined to Sinularia (currently Sclerophytum)-derived metabolites. Huang et al. later described an 8αH-epoxy 9,11-secosteroid from S. granosa, representing only the second natural example reported.12 In our previous study, both 8αH and 8βH analogues were isolated from S. leptoclados, suggesting that this unusual stereochemistry is recurrent but highly restricted within Sclerophytum 9,11-secosteroids.8 Structurally, these metabolites arise from oxidative cleavage of the steroidal C-ring between C-9 and C-11, generating a C-9 ketone adjacent to C-8. The demonstrated C-8 configurational lability suggests that 8αH analogues may arise through enolization/reprotonation after formation of the 9,11-seco-9-one scaffold. The isolation of two 8αH-containing epimeric mixtures in the present study therefore expands this rare structural class and further supports the 8αH configuration as an uncommon, potentially Sclerophytum-enriched stereochemical feature in marine 9,11-secosteroid chemistry. The known compounds 7–12 were identified as 3β-hydroxy-11-acetoxy-24-methylene-9,11-secocholest-5-en-9-one (7),6 (24R)-11-acetoxy-3β-hydroxy-24-methyl-9,11-secocholest-5,22E-dien-9-one (leptosterol B) (8),11 (24S)-3β-hydroxy-11-acetoxy-24-methyl-9,11-secocholest-5-en-9-one (9),6 3β,11-dihydroxy-9,11-secogorgost-5-en-9-one (10),6 3β,11-dihydroxy-24-methylene-9,11-secocholestan-9-one (11),13 and 8βH-3β,11-dihydroxy-24-methylene-9,11-secocholest-5-en-9-one (12),6 respectively, by comparison of their mass spectrometric data and 1H and 13C NMR chemical shifts with those reported in the literature. The in vitro anti-inflammatory activity of steroids 1, 2, 7, 9, 10, 11, and 12 was evaluated using a human neutrophil model. Compounds 3 and 4 were not evaluated because only limited amounts were available after isolation, while compounds 5, 6, and 8 were obtained as inseparable diastereomeric mixtures and were therefore unsuitable for biological evaluation. The results demonstrated that 2, 11, and 12 strongly inhibited both superoxide anion generation and elastase release in fMLF/CB-stimulated human neutrophils, with IC50 values ranging from 2.23 to 5.90 µM (Table 3). In contrast, 9 moderately suppressed elastase release, exhibiting an IC50 value of 7.02 µM (Table 3). Owing to the limited number of compounds evaluated, only preliminary structure–activity relationships can be inferred. Within this small series, compounds bearing a hydroxy group at C-7 or an acetoxy group at C-12 tended to exhibit reduced anti-inflammatory activity, whereas the presence of the C-5,6 olefin appeared to have little influence. Table 3Effects of steroids 1, 2, 7, and 9–12 on superoxide anion generation and elastase release in fMLF/CB-induced human neutrophilsaCompoundSuperoxide anionElastase releaseIC50 (µM)IC50 (µM)1>10>1023.00 ± 0.38***3.25 ± 0.62**7>10>109>107.02 ± 0.3910>10>10115.90 ± 0.24**2.36 ± 0.51***122.63 ± 0.19***2.23 ± 0.16***aIC50: concentration necessary for 50% inhibition. Results are presented as mean ± S.E.M. (n = 3). **p < 0.01, ***p < 0.001 compared with solvent control. Effects of steroids 1, 2, 7, and 9–12 on superoxide anion generation and elastase release in fMLF/CB-induced human neutrophilsa IC50: concentration necessary for 50% inhibition. Results are presented as mean ± S.E.M. (n = 3). **p < 0.01, ***p < 0.001 compared with solvent control. The in vitro anti-hepatic fibrosis activity of steroids 1, 2, 3, 4, 7, 9, 10, 11, and 12 was evaluated using a human hepatic stellate cell (LX-2) model. Compounds 5, 6, and 8 were not tested because they were obtained as inseparable diastereomeric mixtures. The results showed that 7, 10, 11, and 12 strongly inhibited LX-2 cell viability, with IC50 values ranging from 2.61 to 3.47 µM (Table 4), indicating their potential as lead compounds for further anti-hepatic fibrosis studies. Although the number of compounds evaluated was limited, the results suggest that the 9,11-secosteroids generally exhibited stronger inhibitory activity against LX-2 cells than the ergostane-type steroids examined in this study. Likewise, comparison of compounds 1, 11, and 12 suggests that a hydroxy group at C-7 may reduce activity, whereas the C-12 acetoxy group and the C-5,6 olefin appear to have minimal influence. However, these observations should be regarded as preliminary and require validation using a larger set of structurally related analogues. In addition, the absence of a normal hepatocyte control is a limitation of the present study, and further investigations will be required to evaluate the selectivity of these compounds. Table 4Effects of isolated steroids on the cell viability of LX-2 cell lineaCompoundIC50 (µM)1>102>103>104>1072.61 ± 0.08***9>10102.97 ± 0.18***113.10 ± 0.28***123.47 ± 0.14***aIC50: concentration necessary for 50% inhibition. Inh%: results are presented as mean ± S.E.M. (n = 3). ***p < 0.001 compared with solvent control. Effects of isolated steroids on the cell viability of LX-2 cell linea IC50: concentration necessary for 50% inhibition. Inh%: results are presented as mean ± S.E.M. (n = 3). ***p < 0.001 compared with solvent control. Experimental General procedures The specific rotation was measured using a Jasco P-1010 digital polarimeter (Japan Spectroscopic Corporation, Tokyo, Japan). IR spectra were acquired using a IRAffinity-1S spectrometer (Shimadzu, Kyoto, Japan). NMR spectra were recorded on a Bruker Avance-400 and a Bruker Avance-600 NMR spectrometers (Bruker Corporation, Massachusetts, United States) using the residual CHCl3 signal (δH 7.26 ppm) as an international standard for 1H NMR and CDCl3 (δC 77.0 ppm) for 13C NMR, respectively. ESIMS and HRESIMS were recorded using a Shimadzu LC-8045 mass spectrometer and a 6545XT AdvanceBio LC/Q-TOF mass spectrometer (Agilent Technologies, California, United States), respectively. Silica gel (230–400 mesh, Merck, Darmstadt, Germany) was used for open-column chromatography. Preparative and semipreparative reversed-phase HPLC was performed on a system consisting of Shimadzu LC-20AP HPLC pump, Shimadzu CBM-20A system controller, and Shimadzu SPD-M20A diode array detector. Reverse phase columns (Sunniest C18 column, 10 × 250 mm, 5 µm; and Sunniest C18 column, 20 × 250 mm, 5 µm, ChromaNik Technologies Inc., Osaka, Japan) were used for RP-HPLC. Animal material Specimens of the soft coral S. leptoclados were collected by scuba diving off the southern coast of Taiwan in November 2018. These specimens were preserved in a freezer until the extraction process. A voucher specimen (CGUST-C004-2018-NOV) has been deposited at the Center for Drug Research and Development, Chang Gung University of Science and Technology, Taiwan. The identification of this organism was conducted through a comparative analysis with previously documented descriptions.1,14 Extraction and isolation The specimen of S. leptoclados (wet weight/dry weight = 1.74/0.49 kg) was sliced then extraction with ethyl acetate (EtOAc). The EtOAc extract (9.6 g) was applied onto a silica gel column chromatography and fractionated with gradients of n-hexane/EtOAC/MeOH (pure n-hexane–pure EtOAc–pure MeOH, stepwise) to afford 22 fractions (fractions A–V). Fraction M was separated by RP-MPLC using a mixture of MeOH/H2O (v : v = 90 : 10, flow rate = 20 mL min−1) to obtain 9 (15.8 mg) and subfractions M1–M11. Subfraction M6 was purified by RP-HPLC using a mixture of acetonitrile/H2O (v : v = 95 : 5, flow rate = 2 mL min−1) to obtain 7 (42.0 mg). Subfraction M7 was purified by RP-HPLC using a mixture of MeOH/H2O (v : v = 90 : 10, flow rate = 2 mL min−1) to yield mixture 6/8 (3.7 mg). Fraction N was separated by RP-MPLC using a mixture of MeOH/H2O (v : v = 80 : 20, flow rate = 20 mL min−1) to afford subfractions N1–N7. Subfraction N4 was purified by RP-HPLC using a mixture of MeOH/H2O (v : v = 80 : 20, flow rate = 2 mL min−1) to yield mixture 5/7 (3.2 mg). Fraction Q was separated by RP-MPLC using a mixture of MeOH/H2O (v : v = 85 : 15, flow rate = 20 mL min−1) to obtain 10 (12.0 mg) and subfractions Q1–Q7. Subfraction Q4 was purified by silica gel column using a mixture of n-hexane/EtOAc (v : v = 1 : 1) to obtain 12 (7.0 mg). Fraction R was separated by RP-HPLC using a mixture of MeOH/H2O (v : v = 60 : 40 to 100 : 0) to yield subfractions R1–R10. Subfraction R8 was purified by RP-HPLC (ACN/H2O, v : v = 75 : 25, flow rate = 2 mL min−1) to obtain 11 (1.5 mg). Fraction S was separated by RP-HPLC and using a mixture of MeOH/H2O (v : v = 70 : 30, flow rate = 5 mL min−1) to yield 8 subfractions. Subfraction S7 was purified by RP-HPLC (MeOH/H2O, 80 : 20 to 100 : 0, flow rate = 5.0 mL min−1) to obtain 1 (3.3 mg). Fraction T was separated by RP-MPLC using a mixture of MeOH/H2O (v : v = 80 : 20, flow rate = 10 mL min−1) to afford 7 subfractions. Subfraction T7 was purified by RP-HPLC (MeOH/H2O, 90 : 10, flow rate = 2 mL min−1) to obtain 2 (3.6 mg), 3 (1.6 mg) and 4 (0.8 mg). 8βH-3β,7α,11-Trihydroxy-24-methylene-9,11-secocholest-5-en-9-one (1) Colorless oil; [α]26D +1.3 (c 0.004, CHCl3); IR (KBr) vmax 3333, 1713 cm−1; 1H (CDCl3, 400 MHz) and 13C (CDCl3, 100 MHz) NMR data, see Table 1; ESIMS m/z 469 [M + Na]+; HRESIMS m/z 469.3289 (calcd. for C28H46O4 + Na, 469.3293). 3β,5α,12α-Trihydroxy-cholest-6(7),9(11),24(28)-trien (2) Colorless oil; [α]26D −17.6 (c 0.004, CHCl3); IR (KBr) vmax 3387 cm−1; 1H (CDCl3, 400 MHz) and 13C (CDCl3, 100 MHz) NMR data, see Table 1; ESIMS m/z 451 [M + Na]+; HRESIMS m/z 451.3166 (calcd. for C28H44O3 + Na, 451.3188). 3β,7α,12α-Trihydroxy-cholest-5(6),9(11),24(28)-trien (3) Colorless oil; [α]26D −6.2 (c 0.004, CHCl3); IR (KBr) vmax 3332 cm−1; 1H (CDCl3, 400 MHz) and 13C (CDCl3, 100 MHz) NMR data, see Table 1; ESIMS m/z 451 [M + Na]+; HRESIMS m/z 451.3188 (calcd. for C28H44O3 + Na, 451.3188). (24S)-3β,7α,12α-Trihydroxy-cholest-5(6),9(11)-dien (4) Colorless oil; [α]26D −6.6 (c 0.004, CHCl3); IR (KBr) vmax 3363 cm−1; 1H (CDCl3, 600 MHz) and 13C (CDCl3, 150 MHz) NMR data, see Table 1; ESIMS m/z 451 [M + Na]+; HRESIMS m/z 453.3332 (calcd. for C28H46O3 + Na, 453.3344). Mixture of 8αH-3β-hydroxy-11-acetoxy-24-methylene-9,11-secocholest-5-en-9-one (5) and 3β-hydroxy-11-acetoxy-24-methylene-9,11-secocholest-5-en-9-one (7) Colorless oil; [α]26D −24.8 (c 0.004, CHCl3); IR (KBr) vmax 3394, 1712 cm−1; 1H (CDCl3, 400 MHz) and 13C (CDCl3, 100 MHz) NMR data, see Table 2; ESIMS m/z 495 [M + Na]+; HRESIMS m/z 473.3703 (calcd. for C30H48O4 + H, 473.3631). Mixture of 8αH-(24R)-11-acetoxy-3β-hydroxy-24-methyl-9,11-secocholest-5,22E-dien-9-one (6) and (24R)-11-acetoxy-3β-hydroxy-24-methyl-9,11-secocholest-5,22E-dien-9-one (8) Colorless oil; [α]26D −14.4 (c 0.004, CHCl3); IR (KBr) vmax 3394, 1712 cm−1; 1H (CDCl3, 400 MHz) and 13C (CDCl3, 100 MHz) NMR data, see Table 2; ESIMS m/z 495 [M + Na]+; HRESIMS m/z 473.3719 (calcd. for C30H48O4 + H, 473.3631). 3β-Hydroxy-11-acetoxy-24-methylene-9,11-secocholest-5-en-9-one (7) Colorless oil; [α]26D −39.3 (c 0.004, CHCl3); IR (KBr) vmax 3394, 1712 cm−1; 1H (CDCl3, 400 MHz) and 13C (CDCl3, 100 MHz) NMR data, see Table 2; ESIMS m/z 495 [M + Na]+. (24S)-3β-Hydroxy-11-acetoxy-24-methyl-9,11-secocholest-5-en-9-one (9) Colorless oil; [α]26D −30.3 (c 0.004, CHCl3); IR (KBr) vmax 3394, 1712 cm−1; 1H (CDCl3, 400 MHz) and 13C (CDCl3, 100 MHz) NMR data were found to be in agreement with those previous publication;6 ESIMS m/z 497 [M + Na]+. 3β,11-Dihydroxy-9,11-secogorgost-5-en-9-one (10) Colorless oil; [α]26D −22.6 (c 0.004, CHCl3); IR (KBr) vmax 3363 cm−1; 1H (CDCl3, 400 MHz) and 13C (CDCl3, 100 MHz) NMR data were found to be in agreement with those previous publication;6 ESIMS m/z 481 [M + Na]+. 3β,11-Dihydroxy-24-methylene-9,11-secocholestan-9-one (11) Colorless oil; [α]26D −10.4 (c 0.004, CHCl3); IR (KBr) vmax 3309 cm−1; 1H (CDCl3, 400 MHz) and 13C (CDCl3, 100 MHz) NMR data were found to be in agreement with those previous publication;13 ESIMS m/z 455 [M + Na]+; HRESIMS m/z 455.3508 (calcd. for C28H48O3 + Na, 455.3501). 8βH-3β,11-Dihydroxy-24-methylene-9,11-secocholest-5-en-9-one (12) Colorless oil; [α]26D −32.4 (c 0.004, CHCl3); IR (KBr) vmax 3332 and 1705 cm−1; 1H (CDCl3, 400 MHz) and 13C (CDCl3, 100 MHz) NMR data were found to be in agreement with those previous publication;6 ESIMS m/z 453 [M + Na]+; HRESIMS m/z 431.3548 (calcd. for C28H46O3 + H, 431.3525). In vitro anti-inflammatory assay The in vitro anti-inflammatory ability of the steroids 1, 2, 7, 9, 10, 11, and 12 were screened by evaluating their effects on superoxide anion generation and elastase release in fMLF/CB-induced human neutrophils. The preparation of human neutrophils and the measurement of superoxide anion generation and elastase release were performed by following the methods described in our previous publication.15 The protocol for blood collection and neutrophil isolation from healthy human donors was conducted in accordance with the institutional guidelines of Chang Gung Memorial Hospital and approved by the Institutional Review Board of Chang Gung Memorial Hospital (IRB No. 201902217A3). Written informed consent was obtained from all healthy donors prior to blood collection. In vitro anti-hepatic fibrosis assay The in vitro anti-hepatic fibrosis activity of steroids 1, 2, 3, 4, 7, 9, 10, 11, and 12 were evaluated using method modified from the method published in our previous study.16 Briefly, the human hepatic stellate cell line LX-2 (purchased from Sigma-Aldrich, Merck, St. Louis, MO, USA) (5 × 104 cells per well) was seeded in 24-well plates for 24 h. The culture medium was then replaced with serum-free, non-phenol red DMEM (400 µL), followed by treatment with the test compounds for 72 h. After incubation, WST-1 reagent (20 µL per well) was added, and the cells were further incubated at 37 °C for 2 h. Subsequently, 200 µL of the supernatant from each well was transferred to a 96-well plate, and the absorbance was measured at wavelength of 450/620 nm. Conclusions In this study, the chemical composition of the soft coral S. leptoclados was screened, led to the isolation of 12 compounds, including four new steroids, 8βH-3β,7α,11-trihydroxy-24-methylene-9,11-secocholest-5-en-9-one (1), 3β,5α,12α-trihydroxy-cholest-6(7),9(11),24(28)-trien (2), 3β,7α,12α-trihydroxy-cholest-5(6),9(11),24(28)-trien (3), and (24S)-3β,7α,12α-trihydroxy-cholest-5(6),9(11)-dien (4), together with two putatively undescribed C-8 epimeric steroids, 8αH-3β-hydroxy-11-acetoxy-24-methylene-9,11-secocholest-5-en-9-one (5) and 8αH-(24R)-11-acetoxy-3β-hydroxy-24-methyl-9,11-secocholest-5,22E-dien-9-one (6), and six known analogues, 3β-hydroxy-11-acetoxy-24-methylene-9,11-secocholest-5-en-9-one (7), (24R)-11-acetoxy-3β-hydroxy-24-methyl-9,11-secocholest-5,22E-dien-9-one (8), (24S)-3β-hydroxy-11-acetoxy-24-methyl-9,11-secocholest-5-en-9-one (9), 3β,11-dihydroxy-9,11-secogorgost-5-en-9-one (10), 3β,11-dihydroxy-24-methylene-9,11-secocholestan-9-one (11), and 8βH-3β,11-dihydroxy-24-methylene-9,11-secocholest-5-en-9-one (12). The structures of these compounds were determined using spectroscopic methods. The in vitro anti-inflammatory and anti-hepatic fibrosis activities of the isolated steroids were investigated using human neutrophil and human hepatic stellate cell models, respectively. In the results, 2, 11, and 12 strongly inhibited the superoxide anion generation and elastase release in fMLF/CB-induced human neutrophils. And 7, 10, 11, and 12 significantly reduced the cell viability of LX-2 cells. Author contributions Thanh Hao Huynh: methodology, investigation, data curation, formal analysis, writing – original draft. Hsin-Lan Huang: methodology, investigation, data curation, formal analysis. Po-Jen Chen: methodology, investigation, data curation, formal analysis. Yu-Chia Chang: resources, supervision, project administration, funding acquisition. Tsong-Long Hwang: conceptualization, resources, supervision, project administration, funding acquisition, writing – review and editing. Conflicts of interest The authors have declared no conflict of interest. Supplementary Material